Barclays Increases Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $180.00

 

Barclays Increases Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $180.00

Complete the form below to receive the latest headlines and analysts’ recommendations for Jazz Pharmaceuticals with our free daily email newsletter: Other equities research analysts also recently …

More Barclays Increases Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $180.00 Videos

Leave a Reply